KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ: 307750)

Market Cap	185.48B
Revenue (ttm)	134.44B
Net Income (ttm)	6.59B
Shares Out	49.07M
EPS (ttm)	134.02
PE Ratio	28.20
Forward PE	n/a
Dividend	10.00 (0.26%)
Ex-Dividend Date	n/a

Volume	59,104
Average Volume	63,496
Open	3,775.00
Previous Close	3,780.00
Day's Range	3,715.00 - 3,800.00
52-Week Range	3,115.00 - 7,090.00
Beta	-1.00
RSI	53.13
Earnings Date	Feb 27, 2025

About KUKJEON PHARMACEUTICAL

KUKJEON PHARMACEUTICAL Co., Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic materials, such as antistatic agents, monomers and polymers with low dielectric constant, and UV curing agents; low-resistance electrolyte, phosphine, sila...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1972
• Employees: 173
• Stock Exchange: KOSDAQ
• Ticker Symbol: 307750

Financial Performance

In 2023, KUKJEON PHARMACEUTICAL's revenue was 122.00 billion, an increase of 17.63% compared to the previous year's 103.71 billion. Earnings were 4.82 billion, a decrease of -46.09%.